Open-mkt buys · 90d
$152.7K
2 trades · 1 insiders
Open-mkt sales · 90d
$6.7K
2 trades · 1 insiders
Net · 90d
$146.1K
Insiders on file
27
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Binkowski Brent | CHIEF OPERATING OFFICER | 8 | $152.7K | $6.7K | 2026-08-13 |
| SHADAN MARTHA | Director | 9 | $0 | $0 | 2026-06-01 |
| Hill, Mitch C. | Director | 4 | $0 | $0 | 2026-06-01 |
| Jain Mudit K. | Director | 20 | $4.37M | $0 | 2026-06-01 |
| Ballinger Kevin J. | Director | 4 | $0 | $0 | 2026-06-01 |
| Nielsen Kirk G. | Director | 27 | $2.71M | $0 | 2026-06-01 |
| SLATTERY JOSEPH P | Director | 47 | $71.7K | $0 | 2026-06-01 |
| DALE MICHAEL D | Director | 2 | $0 | $0 | 2026-06-01 |
| Adamson Philip B. | Chief Medical Officer | 5 | $0 | $10.0K | 2026-03-02 |
| John Robert Allen | Chief Revenue Officer | 6 | $0 | $31.3K | 2026-03-02 |
| VERRASTRO PAUL | Chief Marketing Officer | 28 | $0 | $171.5K | 2026-03-02 |
| OASHEIM JARED | Chief Financial Officer | 22 | $0 | $13.8K | 2026-03-02 |
| Hykes Kevin | PRES & CEO | 12 | $275.0K | $61.3K | 2026-03-02 |
| Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | 2 | $0 | $0 | 2026-03-02 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | 59 | $0 | $856.5K | 2025-11-26 |
| JOHNSON & JOHNSON | 10% Owner | 4 | $0 | $100.7K | 2025-11-26 |
| Behbahani Ali | Director | 7 | $0 | $0 | 2024-06-04 |
| Palmer Craig E. | SVP, U.S. SALES | 11 | $0 | $0 | 2024-03-25 |
| Yared Nadim | Chief Executive Officer | 27 | $0 | $0 | 2024-02-02 |
| Galle Liz | VP of Global Clinical Research | 6 | $0 | $0 | 2023-10-16 |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | 31 | $0 | $0 | 2022-08-02 |
| NEHRA JOHN M | Director | 6 | $502.6K | $0 | 2022-06-07 |
| BRINTNALL JOHN | Chief Strategy Officer and Sec | 17 | $0 | $0 | 2022-04-22 |
| Pardo Geoffrey B | Director | 4 | $4.95M | $0 | 2021-07-02 |
| NEA PARTNERS 10 L P | 10% Owner | 26 | $4.50M | $0 | 2021-07-02 |
| NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | 15 | $4.06M | $0 | 2021-07-02 |
| GLAXOSMITHKLINE PLC | 10% Owner | 13 | $4.95M | $0 | 2021-07-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Binkowski Brent | CHIEF OPERATING OFFICER | P Buy | 2026-08-13 | 2026-08-13 | 26,223 | $2.91 | $76.3K | 56,514 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | P Buy | 2026-08-13 | 2026-08-13 | 26,223 | $2.91 | $76.4K | 56,514 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | S Sale | 2026-08-12 | 2026-08-13 | 1,309 | $2.55 | $3.3K | 30,291 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | S Sale | 2026-08-12 | 2026-08-13 | 1,309 | $2.55 | $3.3K | 30,291 | SEC↗ |
| DALE MICHAEL D | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 36,252 | — | $0 | 36,252 | SEC↗ |
| SHADAN MARTHA | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 11,182 | — | $0 | 11,182 | SEC↗ |
| Ballinger Kevin J. | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 11,182 | — | $0 | 11,182 | SEC↗ |
| Hill, Mitch C. | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 11,182 | — | $0 | 11,182 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 11,182 | — | $0 | 11,182 | SEC↗ |
| Jain Mudit K. | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 11,182 | — | $0 | 11,182 | SEC↗ |
| Nielsen Kirk G. | Director | A Award deriv | 2026-06-01 | 2026-06-03 | 11,182 | — | $0 | 11,182 | SEC↗ |
| DALE MICHAEL D | Director | A Award | 2026-06-01 | 2026-06-03 | 29,005 | — | $0 | 29,005 | SEC↗ |
| SHADAN MARTHA | Director | A Award | 2026-06-01 | 2026-06-03 | 8,720 | — | $0 | 8,720 | SEC↗ |
| Ballinger Kevin J. | Director | A Award | 2026-06-01 | 2026-06-03 | 8,720 | — | $0 | 8,720 | SEC↗ |
| Hill, Mitch C. | Director | A Award | 2026-06-01 | 2026-06-03 | 8,720 | — | $0 | 8,720 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award | 2026-06-01 | 2026-06-03 | 8,720 | — | $0 | 39,365 | SEC↗ |
| Jain Mudit K. | Director | A Award | 2026-06-01 | 2026-06-03 | 8,720 | — | $0 | 14,370 | SEC↗ |
| Nielsen Kirk G. | Director | A Award | 2026-06-01 | 2026-06-03 | 8,720 | — | $0 | 8,720 | SEC↗ |
| Morrison Gregory | CHIEF HUMAN RESOURCES OFFICE | A Award deriv | 2026-03-02 | 2026-03-04 | 154,500 | — | $0 | 154,500 | SEC↗ |
| John Robert Allen | Chief Revenue Officer | S Sale | 2026-03-02 | 2026-03-03 | 3,964 | $7.90 | $31.3K | 86,036 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | S Sale | 2026-03-02 | 2026-03-03 | 1,744 | $7.90 | $13.8K | 96,703 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2026-03-02 | 2026-03-03 | 1,284 | $7.90 | $10.1K | 60,551 | SEC↗ |
| Hykes Kevin | PRES & CEO | S Sale | 2026-03-02 | 2026-03-03 | 7,763 | $7.90 | $61.3K | 284,237 | SEC↗ |
| Morrison Gregory | CHIEF HUMAN RESOURCES OFFICE | A Award | 2026-03-02 | 2026-03-04 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Adamson Philip B. | Chief Medical Officer | S Sale | 2026-03-02 | 2026-03-16 | 1,262 | $7.90 | $10.0K | 61,578 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | A Award deriv | 2026-02-27 | 2026-03-03 | 23,000 | — | $0 | 23,000 | SEC↗ |
| John Robert Allen | Chief Revenue Officer | A Award deriv | 2026-02-27 | 2026-03-03 | 52,000 | — | $0 | 52,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-02-27 | 2026-03-03 | 91,000 | — | $0 | 91,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award deriv | 2026-02-27 | 2026-03-03 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Hykes Kevin | PRES & CEO | A Award deriv | 2026-02-27 | 2026-03-03 | 238,000 | — | $0 | 238,000 | SEC↗ |
| Adamson Philip B. | Chief Medical Officer | A Award deriv | 2026-02-27 | 2026-03-16 | 62,000 | — | $0 | 62,000 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | A Award | 2026-02-27 | 2026-03-03 | 15,000 | — | $0 | 31,600 | SEC↗ |
| John Robert Allen | Chief Revenue Officer | A Award | 2026-02-27 | 2026-03-03 | 35,000 | — | $0 | 90,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award | 2026-02-27 | 2026-03-03 | 61,000 | — | $0 | 98,447 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award | 2026-02-27 | 2026-03-03 | 45,000 | — | $0 | 61,835 | SEC↗ |
| Hykes Kevin | PRES & CEO | A Award | 2026-02-27 | 2026-03-03 | 159,000 | — | $0 | 292,000 | SEC↗ |
| Adamson Philip B. | Chief Medical Officer | A Award | 2026-02-27 | 2026-03-16 | 41,000 | — | $0 | 62,840 | SEC↗ |
| Jain Mudit K. | Director | P Buy | 2026-02-20 | 2026-02-23 | 46,800 | $6.36 | $297.6K | 980,183 | SEC↗ |
| Jain Mudit K. | Director | P Buy | 2026-02-18 | 2026-02-18 | 600 | $4.64 | $2.8K | 5,650 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | S Sale | 2025-11-26 | 2026-01-08 | 6,337 | $10.03 | $63.6K | 4,024,861 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | S Sale | 2025-11-26 | 2025-12-01 | 6,337 | $10.03 | $63.6K | 4,040,861 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | S Sale | 2025-11-25 | 2026-01-08 | 16,000 | $10.03 | $160.5K | 4,031,198 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | S Sale | 2025-11-24 | 2025-11-25 | 2,200 | $10.06 | $22.1K | 4,047,198 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | S Sale | 2025-11-21 | 2025-11-25 | 500 | $10.00 | $5.0K | 4,049,398 | SEC↗ |
| JOHNSON & JOHNSON | 10% Owner | S Sale | 2025-11-12 | 2025-11-14 | 1,000 | $10.00 | $10.0K | 4,049,898 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | S Sale | 2025-11-07 | 2025-11-10 | 200 | $10.00 | $2.0K | 4,050,898 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | S Sale | 2025-11-06 | 2025-11-10 | 52,332 | $10.21 | $534.3K | 4,051,098 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | A Award deriv | 2025-08-11 | 2025-08-13 | 74,900 | — | $0 | 74,900 | SEC↗ |
| Binkowski Brent | CHIEF OPERATING OFFICER | A Award | 2025-08-11 | 2025-08-13 | 16,600 | — | $0 | 16,600 | SEC↗ |
| SHADAN MARTHA | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 19,554 | — | $0 | 19,554 | SEC↗ |
| Ballinger Kevin J. | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 19,554 | — | $0 | 19,554 | SEC↗ |
| Hill, Mitch C. | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 19,554 | — | $0 | 19,554 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 19,554 | — | $0 | 19,554 | SEC↗ |
| Jain Mudit K. | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 19,554 | — | $0 | 19,554 | SEC↗ |
| Nielsen Kirk G. | Director | A Award deriv | 2025-06-03 | 2025-06-05 | 19,554 | — | $0 | 19,554 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2025-05-15 | 2025-05-19 | 10,966 | $5.45 | $59.8K | 1,910,134 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2025-05-14 | 2025-05-14 | 61,200 | $5.23 | $320.1K | 1,899,168 | SEC↗ |
| Jain Mudit K. | Director | P Buy | 2025-05-13 | 2025-05-13 | 150 | $5.26 | $789 | 5,050 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2025-05-13 | 2025-05-14 | 101,413 | $5.29 | $536.5K | 1,837,968 | SEC↗ |
| Hykes Kevin | PRES & CEO | P Buy | 2025-05-12 | 2025-05-12 | 5,000 | $4.84 | $24.2K | 133,000 | SEC↗ |
| Jain Mudit K. | Director | P Buy | 2025-05-12 | 2025-05-13 | 1,500 | $4.66 | $7.0K | 4,900 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2025-05-12 | 2025-05-14 | 25,200 | $4.79 | $120.7K | 1,736,555 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award deriv | 2025-02-28 | 2025-03-04 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Adamson Philip B. | Chief Medical Officer | A Award deriv | 2025-02-28 | 2025-03-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-02-28 | 2025-03-04 | 33,000 | — | $0 | 33,000 | SEC↗ |
| John Robert Allen | Chief Revenue Officer | A Award deriv | 2025-02-28 | 2025-03-04 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Hykes Kevin | PRES & CEO | A Award deriv | 2025-02-28 | 2025-03-04 | 148,000 | — | $0 | 148,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award | 2025-02-28 | 2025-03-04 | 16,000 | — | $0 | 16,835 | SEC↗ |
| Adamson Philip B. | Chief Medical Officer | A Award | 2025-02-28 | 2025-03-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award | 2025-02-28 | 2025-03-04 | 22,000 | — | $0 | 37,447 | SEC↗ |
| John Robert Allen | Chief Revenue Officer | A Award | 2025-02-28 | 2025-03-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Hykes Kevin | PRES & CEO | A Award | 2025-02-28 | 2025-03-04 | 98,000 | — | $0 | 128,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G Gift | 2024-11-21 | 2024-11-21 | 1,040 | — | $0 | 835 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise deriv | 2024-11-19 | 2024-11-21 | 2,500 | — | $0 | 73,306 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise | 2024-11-19 | 2024-11-21 | 2,500 | $5.14 | $12.8K | 3,305 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2024-11-19 | 2024-11-21 | 1,430 | $13.58 | $19.4K | 1,875 | SEC↗ |
| Hill, Mitch C. | Director | A Award deriv | 2024-09-03 | 2024-09-05 | 36,136 | — | $0 | 36,136 | SEC↗ |
| Ballinger Kevin J. | Director | A Award deriv | 2024-09-03 | 2024-09-05 | 36,136 | — | $0 | 36,136 | SEC↗ |
| SLATTERY JOSEPH P | Director | P Buy | 2024-08-15 | 2024-08-15 | 3,000 | $8.10 | $24.3K | 30,645 | SEC↗ |
| SLATTERY JOSEPH P | Director | P Buy | 2024-08-08 | 2024-08-08 | 3,000 | $8.24 | $24.7K | 27,645 | SEC↗ |
| SLATTERY JOSEPH P | Director | P Buy | 2024-08-06 | 2024-08-06 | 2,500 | $9.09 | $22.7K | 24,645 | SEC↗ |
| Hykes Kevin | PRES & CEO | P Buy | 2024-08-05 | 2024-08-05 | 30,000 | $8.36 | $250.8K | 30,000 | SEC↗ |
| Hykes Kevin | PRES & CEO | A Award deriv | 2024-07-31 | 2024-08-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| John Robert Allen | Chief Revenue Officer | A Award deriv | 2024-06-27 | 2024-07-01 | 122,192 | — | $0 | 122,192 | SEC↗ |
| Nielsen Kirk G. | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 20,961 | — | $0 | 20,961 | SEC↗ |
| SHADAN MARTHA | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 20,961 | — | $0 | 20,961 | SEC↗ |
| Jain Mudit K. | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 20,961 | — | $0 | 20,961 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 20,961 | — | $0 | 20,961 | SEC↗ |
| Behbahani Ali | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 20,961 | — | $0 | 20,961 | SEC↗ |
| SHADAN MARTHA | Director | A Award deriv | 2024-06-04 | 2024-06-07 | 27,250 | — | $0 | 27,250 | SEC↗ |
| Jain Mudit K. | Director | A Award deriv | 2024-06-04 | 2024-06-07 | 27,250 | — | $0 | 27,250 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award deriv | 2024-06-04 | 2024-06-07 | 27,250 | — | $0 | 27,250 | SEC↗ |
| Nielsen Kirk G. | Director | A Award deriv | 2024-06-04 | 2024-06-07 | 27,250 | — | $0 | 27,250 | SEC↗ |
| Behbahani Ali | Director | A Award deriv | 2024-06-04 | 2024-06-07 | 27,250 | — | $0 | 27,250 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise deriv | 2024-03-25 | 2024-03-27 | 404 | — | $0 | 0 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise deriv | 2024-03-25 | 2024-03-27 | 151 | — | $0 | 0 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise deriv | 2024-03-25 | 2024-03-27 | 379 | — | $0 | 0 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise | 2024-03-25 | 2024-03-27 | 379 | $0.24 | $91 | 674 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise | 2024-03-25 | 2024-03-27 | 404 | $0.24 | $97 | 1,078 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise | 2024-03-25 | 2024-03-27 | 151 | $0.24 | $36 | 1,229 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 118 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 165 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 189 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 158 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 23 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 758 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 85 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 79 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 252 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 142 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 442 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 300 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 584 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 489 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise deriv | 2024-02-29 | 2024-03-06 | 71 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 79 | $5.14 | $406 | 4,103,430 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 158 | $0.24 | $38 | 4,099,733 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 189 | $0.24 | $45 | 4,099,922 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 165 | $0.24 | $40 | 4,100,087 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 118 | $0.24 | $28 | 4,100,205 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 71 | $0.24 | $17 | 4,100,276 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 23 | $0.24 | $6 | 4,100,299 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 85 | $0.24 | $20 | 4,100,384 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 758 | $0.24 | $182 | 4,101,142 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 489 | $0.24 | $117 | 4,101,631 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 584 | $0.24 | $140 | 4,102,215 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 300 | $0.24 | $72 | 4,102,515 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 442 | $1.19 | $526 | 4,102,957 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 252 | $3.96 | $998 | 4,103,351 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | M Exercise | 2024-02-29 | 2024-03-06 | 142 | $1.19 | $169 | 4,103,099 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G Gift | 2024-02-23 | 2024-02-27 | 1,650 | — | $0 | 805 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise deriv | 2024-02-20 | 2024-02-22 | 5,000 | — | $0 | 75,806 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise | 2024-02-20 | 2024-02-22 | 5,000 | $5.14 | $25.7K | 5,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2024-02-20 | 2024-02-22 | 2,545 | $21.91 | $55.8K | 2,455 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | X Exercise deriv | 2024-02-16 | 2024-03-06 | 607,225 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | X Exercise | 2024-02-16 | 2024-03-06 | 607,725 | $0.16 | $97.2K | 4,103,300 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | S Sale | 2024-02-16 | 2024-03-06 | 3,725 | $25.81 | $96.1K | 4,099,575 | SEC↗ |
| Hykes Kevin | PRES & CEO | A Award deriv | 2024-02-12 | 2024-02-14 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-02-02 | 2024-02-06 | 22,050 | — | $0 | 22,050 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award deriv | 2024-02-02 | 2024-02-06 | 32,000 | — | $0 | 32,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-02-02 | 2024-02-06 | 55,500 | — | $0 | 55,500 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | A Award deriv | 2024-02-02 | 2024-02-06 | 31,600 | — | $0 | 31,600 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-01-29 | 2024-01-31 | 4,055 | — | $0 | 0 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-01-29 | 2024-01-31 | 1,945 | — | $0 | 29,092 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-01-29 | 2024-01-31 | 4,055 | $0.24 | $973 | 24,310 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-01-29 | 2024-01-31 | 1,945 | $0.24 | $467 | 26,255 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2023-12-28 | 2024-01-02 | 224 | — | $0 | 0 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2023-12-28 | 2024-01-02 | 1,456 | — | $0 | 0 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2023-12-28 | 2024-01-02 | 174 | — | $0 | 0 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2023-12-28 | 2024-01-02 | 96 | — | $0 | 7,590 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise | 2023-12-28 | 2024-01-02 | 174 | $1.19 | $207 | 22,049 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise | 2023-12-28 | 2024-01-02 | 224 | $0.24 | $54 | 20,419 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise | 2023-12-28 | 2024-01-02 | 96 | $3.96 | $380 | 22,145 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise | 2023-12-28 | 2024-01-02 | 1,456 | $0.24 | $349 | 21,875 | SEC↗ |
| Behbahani Ali | Director | M Exercise deriv | 2023-12-14 | 2023-12-18 | 316 | — | $0 | 0 | SEC↗ |
| Behbahani Ali | Director | M Exercise | 2023-12-14 | 2023-12-18 | 316 | $0.24 | $76 | 316 | SEC↗ |
| Galle Liz | VP OF GLOBAL CLINICAL RESEAR | M Exercise deriv | 2023-10-16 | 2023-10-18 | 778 | — | $0 | 0 | SEC↗ |
| Galle Liz | VP OF GLOBAL CLINICAL RESEAR | M Exercise | 2023-10-16 | 2023-10-18 | 778 | $0.24 | $187 | 778 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2023-09-18 | 2023-09-20 | 5,335 | — | $0 | 11,732 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2023-09-18 | 2023-09-20 | 527 | — | $0 | 0 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise | 2023-09-18 | 2023-09-20 | 527 | $0.24 | $126 | 10,112 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise | 2023-09-18 | 2023-09-20 | 5,335 | $3.96 | $21.1K | 15,447 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 489 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 85 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 23 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 71 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 118 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 165 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 189 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 158 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 237 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 1,264 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 142 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 758 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other deriv | 2023-09-15 | 2024-02-02 | 300 | — | $0 | 0 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | J Other | 2023-09-15 | 2023-09-18 | 3,495,575 | — | $0 | 0 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2023-08-03 | 2023-08-07 | 628 | $18.55 | $11.6K | 0 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G Gift | 2023-08-02 | 2023-08-02 | 2,000 | — | $0 | 628 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise deriv | 2023-07-31 | 2023-08-02 | 3,750 | $5.14 | $19.3K | 80,806 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise | 2023-07-31 | 2023-08-02 | 3,750 | $5.14 | $19.3K | 3,750 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2023-07-31 | 2023-08-02 | 1,122 | $17.49 | $19.6K | 2,628 | SEC↗ |
| Nielsen Kirk G. | Director | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| SHADAN MARTHA | Director | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| Hykes Kevin | Director | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| Jain Mudit K. | Director | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| Behbahani Ali | Director | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise deriv | 2023-05-16 | 2023-05-18 | 295 | — | $0 | 0 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | M Exercise | 2023-05-16 | 2023-05-18 | 295 | $0.24 | $71 | 295 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | A Award deriv | 2023-01-18 | 2023-01-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award deriv | 2023-01-18 | 2023-01-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award deriv | 2023-01-18 | 2023-01-20 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | A Award deriv | 2023-01-18 | 2023-01-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Galle Liz | VP OF GLOBAL CLINICAL RESEAR | A Award deriv | 2023-01-18 | 2023-01-20 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | G Gift | 2023-01-11 | 2023-01-13 | 7,080 | — | $0 | 20,255 | SEC↗ |
| Hykes Kevin | Director | A Award deriv | 2022-12-21 | 2022-12-23 | 5,246 | — | $0 | 5,246 | SEC↗ |
| Hykes Kevin | Director | A Award deriv | 2022-12-21 | 2022-12-23 | 21,776 | — | $0 | 21,776 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | G Gift | 2022-11-30 | 2022-11-30 | 4,400 | — | $0 | 0 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise deriv | 2022-11-28 | 2022-11-30 | 9,000 | — | $0 | 84,556 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2022-11-28 | 2022-11-30 | 600 | $12.52 | $7.5K | 4,400 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | S Sale | 2022-11-28 | 2022-11-30 | 4,000 | $11.85 | $47.4K | 5,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | M Exercise | 2022-11-28 | 2022-11-30 | 9,000 | $5.14 | $46.3K | 9,000 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | A Award deriv | 2022-08-02 | 2022-08-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-08-02 | 2022-08-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Palmer Craig E. | SVP, U.S. SALES | A Award deriv | 2022-08-02 | 2022-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BRUHN-DING DEAN | VP OF REG. AFFAIRS AND QA | A Award deriv | 2022-08-02 | 2022-08-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Galle Liz | VP OF GLOBAL CLINICAL RESEAR | A Award deriv | 2022-08-02 | 2022-08-04 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | A Award deriv | 2022-08-02 | 2022-08-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SLATTERY JOSEPH P | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| Nielsen Kirk G. | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| NEHRA JOHN M | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| SHADAN MARTHA | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| Jain Mudit K. | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| Behbahani Ali | Director | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-06-02 | 2022-06-06 | 2,633 | — | $0 | 527 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-06-02 | 2022-06-06 | 1,264 | — | $0 | 0 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-06-02 | 2022-06-06 | 2,528 | — | $0 | 0 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-06-02 | 2022-06-06 | 3,160 | — | $0 | 0 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise | 2022-06-02 | 2022-06-06 | 3,160 | $0.24 | $758 | 6,952 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise | 2022-06-02 | 2022-06-06 | 2,528 | $0.24 | $607 | 3,792 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise | 2022-06-02 | 2022-06-06 | 1,264 | $0.24 | $303 | 1,264 | SEC↗ |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | M Exercise | 2022-06-02 | 2022-06-06 | 2,633 | $0.24 | $632 | 9,585 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-24 | 2022-05-26 | 8,070 | $5.05 | $40.8K | 1,711,355 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-23 | 2022-05-23 | 4,432 | $5.04 | $22.3K | 1,703,285 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-20 | 2022-05-23 | 13,387 | $5.04 | $67.5K | 1,698,853 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-19 | 2022-05-23 | 10,976 | $5.04 | $55.3K | 1,685,466 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-05 | 2022-05-05 | 3,992 | $6.00 | $24.0K | 1,674,490 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-04 | 2022-05-05 | 25,503 | $5.99 | $152.8K | 1,670,498 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-03 | 2022-05-05 | 32,809 | $6.00 | $196.9K | 1,644,995 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-05-02 | 2022-05-02 | 41,988 | $5.97 | $250.7K | 1,612,186 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-04-28 | 2022-05-02 | 100 | $5.97 | $597 | 1,570,198 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2022-04-25 | 2022-04-27 | 6,059 | — | $0 | 4,055 | SEC↗ |
| Yared Nadim | CHIEF EXECUTIVE OFFICER | M Exercise | 2022-04-25 | 2022-04-27 | 6,059 | $0.24 | $1.5K | 27,335 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise deriv | 2022-04-22 | 2022-04-26 | 1,264 | — | $0 | 0 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise deriv | 2022-04-22 | 2022-04-26 | 1,590 | — | $0 | 685 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise deriv | 2022-04-22 | 2022-04-26 | 2,584 | — | $0 | 702 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise deriv | 2022-04-22 | 2022-04-26 | 2,221 | — | $0 | 0 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise deriv | 2022-04-22 | 2022-04-26 | 3,792 | — | $0 | 0 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise | 2022-04-22 | 2022-04-26 | 2,584 | $0.24 | $620 | 14,624 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise | 2022-04-22 | 2022-04-26 | 2,221 | $0.24 | $533 | 16,845 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise | 2022-04-22 | 2022-04-26 | 3,792 | $0.24 | $910 | 20,637 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise | 2022-04-22 | 2022-04-26 | 1,264 | $0.24 | $303 | 21,901 | SEC↗ |
| BRINTNALL JOHN | CHIEF STRATEGY OFFICER AND S | M Exercise | 2022-04-22 | 2022-04-26 | 1,590 | $0.24 | $382 | 12,040 | SEC↗ |
| Jain Mudit K. | Director | P Buy | 2022-02-28 | 2022-03-02 | 600 | $9.03 | $5.4K | 3,400 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-02-24 | 2022-02-28 | 3,400 | $8.24 | $28.0K | 1,570,098 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-02-23 | 2022-02-23 | 38,200 | $8.04 | $307.1K | 1,566,698 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-02-22 | 2022-02-23 | 40,008 | $7.94 | $317.7K | 1,528,498 | SEC↗ |
| Nielsen Kirk G. | Director | P Buy | 2022-02-18 | 2022-02-23 | 26,659 | $7.92 | $211.1K | 1,488,490 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 1,590 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 378 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 821 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 2,528 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 2,275 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 5,158 | — | $0 | 2,048 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 1,169 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 2,528 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 1,264 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 1,264 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 2,862 | — | $0 | 0 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 12,383 | — | $0 | 4,128 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise deriv | 2022-02-08 | 2022-02-10 | 780 | — | $0 | 315 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 12,383 | $0.24 | $3.0K | 32,811 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 780 | $0.24 | $187 | 20,428 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 2,862 | $0.24 | $687 | 35,673 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 1,264 | $0.24 | $303 | 36,937 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 1,264 | $0.24 | $303 | 38,201 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 5,158 | $0.24 | $1.2K | 54,648 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 2,275 | $0.24 | $546 | 49,490 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 2,528 | $0.24 | $607 | 47,215 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 1,590 | $0.24 | $382 | 44,687 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 378 | $0.24 | $91 | 43,097 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 821 | $0.24 | $197 | 42,719 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 1,169 | $0.24 | $281 | 41,898 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | M Exercise | 2022-02-08 | 2022-02-10 | 2,528 | $0.24 | $607 | 40,729 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise deriv | 2022-02-03 | 2022-02-07 | 1,266 | — | $0 | 11,375 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise deriv | 2022-02-03 | 2022-02-07 | 5,916 | — | $0 | 0 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise deriv | 2022-02-03 | 2022-02-07 | 3,792 | — | $0 | 0 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise deriv | 2022-02-03 | 2022-02-07 | 5,057 | — | $0 | 0 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise deriv | 2022-02-03 | 2022-02-07 | 2,659 | — | $0 | 0 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise | 2022-02-03 | 2022-02-07 | 5,916 | $0.24 | $1.4K | 20,010 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise | 2022-02-03 | 2022-02-07 | 2,659 | $0.24 | $638 | 5,245 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise | 2022-02-03 | 2022-02-07 | 1,266 | $0.24 | $304 | 21,276 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise | 2022-02-03 | 2022-02-07 | 3,792 | $0.24 | $910 | 14,094 | SEC↗ |
| Yared Nadim | Chief Executive Officer | M Exercise | 2022-02-03 | 2022-02-07 | 5,057 | $0.24 | $1.2K | 10,302 | SEC↗ |
| Yared Nadim | Chief Executive Officer | G Gift | 2022-01-19 | 2022-01-20 | 10,500 | — | $0 | 2,586 | SEC↗ |
| Yared Nadim | Chief Executive Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 186,400 | — | $0 | 186,400 | SEC↗ |
| Galle Liz | VP of Global Clinical Resear | A Award deriv | 2022-01-18 | 2022-01-20 | 25,900 | — | $0 | 25,900 | SEC↗ |
| BRUHN-DING DEAN | VP of Reg. Affairs and QA | A Award deriv | 2022-01-18 | 2022-01-20 | 23,600 | — | $0 | 23,600 | SEC↗ |
| OASHEIM JARED | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 56,200 | — | $0 | 56,200 | SEC↗ |
| VERRASTRO PAUL | Chief Marketing Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 41,200 | — | $0 | 41,200 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 189 | — | $0 | 0 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 3,917 | — | $0 | 1,456 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 2,149 | — | $0 | 224 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 316 | — | $0 | 0 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 316 | — | $0 | 0 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 584 | — | $0 | 174 | SEC↗ |
| SLATTERY JOSEPH P | Director | M Exercise deriv | 2022-01-13 | 2022-01-18 | 758 | — | $0 | 0 | SEC↗ |